These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2789099)

  • 21. [Bepridil--electrophysiologic properties of a new calcium antagonist with an anti-arrhythmia effect].
    Zehender M; Geibel A; Henning B; Hohnloser S; Meinertz T; Just H
    Z Kardiol; 1988 Feb; 77(2):93-8. PubMed ID: 3259053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of pimobendan (UD-CG 115 BS), a new positive inotropic agent, on ventricular tachycardia and ischemic ventricular fibrillation in a conscious canine model of recent myocardial infarction.
    Lynch JJ; Kitzen JM; Hoff PT; Lucchesi BR
    J Cardiovasc Pharmacol; 1988; 12(5):547-54. PubMed ID: 2468054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ectopic ventricular tachycardia sensitive to calcium antagonists in acute myocardial infarction in dogs.
    Miyazaki T; Ogawa S; Sakurai K; Mori H; Yamazaki H; Nakamura Y
    Am J Cardiol; 1985 Apr; 55(8):1085-90. PubMed ID: 3984871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiologic effects of bepridil in patients with refractory ventricular tachycardia assessed by programmed electrical stimulation.
    Schmitt C; Brachmann J; Hölzel C; Waldecker B; Schöls W; Beyer T; Kübler W
    Clin Cardiol; 1990 Dec; 13(12):864-8. PubMed ID: 2282730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of pirmenol on electrical induction of sustained ventricular tachycardia in a seven-day-old canine myocardial infarction.
    Nitta J; Nogami A; Aonuma K; Akimoto H; Chung YH; Takahashi A; Iesaka Y; Marumo F; Hiraoka M
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):54-60. PubMed ID: 1708056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiological mechanisms of action of ethmozine that explain its antiarrhythmic efficacy in the late stage of experimental myocardial infarction in dogs.
    Aidonidis I; Egel E; Hilbel T; Rizos I; Kuebler W; Brachmann J
    Eur Heart J; 1994 Dec; 15(12):1698-704. PubMed ID: 7698141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inducible sustained ventricular tachycardia 4 years after experimental canine myocardial infarction: electrophysiologic and anatomic comparisons with early healed infarcts.
    Hanich RF; de Langen CD; Kadish AH; Michelson EL; Levine JH; Spear JF; Moore EN
    Circulation; 1988 Feb; 77(2):445-56. PubMed ID: 3338134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inducible sustained ventricular tachycardia and ventricular fibrillation in conscious dogs with isolated right ventricular infarction: relation to infarct structure.
    Karagueuzian HS; Sugi K; Ohta M; Fishbein MC; Mandel WJ; Peter T
    J Am Coll Cardiol; 1986 Apr; 7(4):850-8. PubMed ID: 3958343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs.
    Beaughard M; Michelin MT; Tisne-Versailles J; Lamar JC
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):276-96. PubMed ID: 3493742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of ventricular tachyarrhythmias in the conscious canine during the recovery phase of experimental ischemic injury: effect of bethanidine administration.
    Patterson E; Amalfitano DJ; Lucchesi BR
    J Cardiovasc Pharmacol; 1984; 6(3):470-5. PubMed ID: 6202974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicardipine, nitrendipine, and bepridil: new calcium antagonists for cardiovascular disorders.
    Hasegawa GR
    Clin Pharm; 1988 Feb; 7(2):97-108. PubMed ID: 3280222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lidocaine converts inducible ventricular fibrillation into sustained ventricular tachycardia in conscious dogs with recent myocardial infarction.
    Aidonidis I; Brachmann J; Rizos I; Toutouzas P; Kübler W
    Cardiology; 1994; 85(6):378-87. PubMed ID: 7697673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iontophoretic transmyocardial drug delivery. A novel approach to antiarrhythmic drug therapy.
    Avitall B; Hare J; Zander G; Bockoff C; Tchou P; Jazayeri M; Akhtar M
    Circulation; 1992 Apr; 85(4):1582-93. PubMed ID: 1555296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiological profile of bepridil, a new anti-anginal drug with calcium blocking properties.
    Flammang D; Waynberger M; Jansen FH; Paillet R; Coumel P
    Eur Heart J; 1983 Sep; 4(9):657-54. PubMed ID: 6605854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anti-ischaemic activity of the novel compound, CERM 11956, compared with that of bepridil and nifedipine in isolated guinea-pig hearts.
    Boddeke EW; Wilffert B; Heynis JB; Hugtenburg JG; Jap WT; Veldsema-Currie RD; Van Zwieten PA
    Eur J Pharmacol; 1988 May; 149(3):195-203. PubMed ID: 3261692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping of septal ventricular tachycardia: clinical and experimental correlations.
    Kawamura Y; Pagé PL; Cardinal R; Savard P; Nadeau R
    J Thorac Cardiovasc Surg; 1996 Oct; 112(4):914-25. PubMed ID: 8873717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facilitation of lethal ventricular arrhythmias by therapeutic digoxin in conscious post infarction dogs.
    Lynch JJ; Montgomery DG; Lucchesi BR
    Am Heart J; 1986 May; 111(5):883-90. PubMed ID: 3706108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Day to day variations in morphology and duration of fragmented ventricular potentials during the late post-myocardial infarction phase in conscious dogs.
    Cobbe SM; Hoffman E; Ritzenhoff A; Brachmann J; Kübler W; Senges J
    Eur Heart J; 1985 Aug; 6(8):672-80. PubMed ID: 4054137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic and electrophysiological effects of SD-3212, a novel Na+ and Ca++ channel blocker, in anaesthetized dogs with myocardial infarction in comparison with its stereoisomer (SD-3211) and bepridil.
    Nagashima S; Uematsu T; Araki S; Matsuzaki T; Fukuchi M; Hashimoto H; Nakashima M
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jun; 345(6):688-95. PubMed ID: 1321957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.